METiS TechBio licenses drug candidate to Boulevard Bio for $1.6B

Markets Investing.com By Investing.com 30 Jun 2026 09:40 1 min read

METiS TechBio licenses drug candidate to Boulevard Bio for $1.6B

METiS TechBio licenses drug candidate to Boulevard Bio for $1.6B

METiS TechBio licenses drug candidate to Boulevard Bio for $1.6B

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.